Name | methyl 4-methyl-5-nitropyridine-2-carboxylate |
---|---|
Synonyms |
Methyl 4-methyl-5-nitro-2-pyridinecarboxylate
2-Pyridinecarboxylic acid, 4-methyl-5-nitro-, methyl ester 4-methyl-5-nitro-pyridine-2-carboxylic acid methyl ester methyl 4-methyl-5-nitropicolinate |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 356.9±42.0 °C at 760 mmHg |
Molecular Formula | C8H8N2O4 |
Molecular Weight | 196.160 |
Flash Point | 169.6±27.9 °C |
Exact Mass | 196.048401 |
PSA | 85.01000 |
LogP | 0.68 |
Vapour Pressure | 0.0±0.8 mmHg at 25°C |
Index of Refraction | 1.552 |
Hazard Codes | Xi |
---|---|
HS Code | 2933399090 |
~% 868551-30-8 |
Literature: NOVARTIS AG; HOMMEL, Ulrich; LORTHIOIS, Edwige Liliane Jeanne; MAIBAUM, Juergen Klaus; OSTERMANN, Nils; RANDL, Stefan Andreas; VULPETTI, Anna Patent: WO2014/2057 A1, 2014 ; Location in patent: Page/Page column 56 ; |
Precursor 2 | |
---|---|
DownStream 1 | |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |